About Memorial Healthcare Institute for Neurosciences and Multiple Sclerosis
"At the Memorial Healthcare Institute for Neurosciences and Multiple Sclerosis, you will find experts in the neurology field who have extensive experience. Our providers are Rany Aburashed, DO, Robert Pace, MD, Margaret Frey, DO, Cara Leahy, DO and Ali Saeed, MD. Services and Conditions treated: Dementia EEG & EMG Epilepsy Headache/Migraine Movement disorders Multiple Sclerosis Myopathies Neuromuscular diseases Neuropathy Parkinson’s Disease Peripheral Neuropathies Stroke management …and much more New Patients Welcome. Call Today. 989-723-1390"
Clinical Trials at Memorial Healthcare Institute for Neurosciences and Multiple Sclerosis
During the past decade, Memorial Healthcare Institute for Neurosciences and Multiple Sclerosis conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Memorial Healthcare Institute for Neurosciences and Multiple Sclerosis
According to Clinical.Site data, the most researched conditions in "Memorial Healthcare Institute for Neurosciences and Multiple Sclerosis" are
"Relapsing Multiple Sclerosis" (2 trials), "Multiple Sclerosis" (1 trials), "Multiple Sclerosis (MS)" (1 trials) and "Primary Progressive Multiple Sclerosis" (1 trials). Many other conditions were trialed in "Memorial Healthcare Institute for Neurosciences and Multiple Sclerosis" in a lesser frequency.
Clinical Trials Intervention Types at Memorial Healthcare Institute for Neurosciences and Multiple Sclerosis
Most popular intervention types in "Memorial Healthcare Institute for Neurosciences and Multiple Sclerosis" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Ocrelizumab" (2 trials), "Antihistamine" (1 trials), "Desloratadine given orally" (1 trials), "Dexamethasone given orally" (1 trials) and "Diphenhydramine IV" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Memorial Healthcare Institute for Neurosciences and Multiple Sclerosis
The vast majority of trials in "Memorial Healthcare Institute for Neurosciences and Multiple Sclerosis" are
4 trials for "All" genders.
Clinical Trials Status at Memorial Healthcare Institute for Neurosciences and Multiple Sclerosis
Currently, there are NaN active trials in "Memorial Healthcare Institute for Neurosciences and Multiple Sclerosis".
undefined are not yet recruiting,
3 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Memorial Healthcare Institute for Neurosciences and Multiple Sclerosis,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Memorial Healthcare Institute for Neurosciences and Multiple Sclerosis, 1 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".